- ... RECEPTOR. It is used in the treatment of advanced RENAL CELL CARCINOMA. Parent Heading: Benzamides D02.065. ... of PACLITAXEL used in the treatment of locally advanced or metastatic BREAST NEOPLASMS and NON- SMALL CELL ...
- ... RECEPTOR. It is used in the treatment of advanced RENAL CELL CARCINOMA. Tree locations: Benzamides D02.065. ... of PACLITAXEL used in the treatment of locally advanced or metastatic BREAST NEOPLASMS and NON-SMALL CELL ...
- ... 1 D12.776.543.750.615 Receptor for Advanced Glycation End Products D12.776.543.750.630 ... Protein Degradation End Products D12.776.643.249 Advanced Oxidation Protein Products D12.776.643.500 Glycation ...
- ... Receptors, Cell Surface D12.776.543.750.006...........................................Advanced Glycosylation End Product-Specific Receptor D12.776.543. ...
- ... Phosphatases, Class 1 Antigens, CD45 Receptors, Cell Surface Advanced Glycosylation End Product-Specific Receptor Antigens, CD36 Asialoglycoprotein ... 4 Subunit Protein Corona Protein Degradation End Products Advanced Oxidation Protein Products Glycosylation End Products, Advanced 1, ...
- ... course AC I ION POTENTIALS, indexing policy change ADVANCED TRAINING aq«neJ.i n«u curriculum (AT) ... award of CEU'i new eddreii n*u advanced Training curriculum new advanced training agenda ichedule, 1979 ...
- ... by reversing glycation and prevent the formation of ADVANCED GLYCATION END PRODUCTS. It protects cells against OXIDATIVE ...
7 results